Excision Medical
Excision Medical, founded in 2020, innovates in the TAVR market with reliable leaflet modification devices.
Founded
2020Excision Medical, founded in 2020, innovates in the TAVR market with reliable leaflet modification devices.
Excision Medical, founded in 2020 and based in Malvern, Pennsylvania, is dedicated to advancing the transcatheter aortic valve replacement (TAVR) market. The company's core mission is to develop reliable and safe leaflet modification systems to manage aortic stenosis over a patient's lifetime. Their primary product, the Excision RF System, aims to address the unmet needs in treating aortic valve stenosis, a prevalent valvular heart disease. Excision Medical's innovations target a significant market, with TAVR procedures representing a $5 billion industry.
Notable figures affiliated with Excision Medical include experienced professionals from the medical device and cardiovascular sectors. The company has attracted attention from investors focused on medical technology advancements. Key achievements include the development of their proprietary leaflet modification system and progress towards addressing critical gaps in TAVR treatments. Excision Medical's impact lies in potentially transforming the management of aortic stenosis, offering improved outcomes for patients and contributing to the evolution of cardiovascular care.
Companies similar to Excision Medical include Moray Medical, Capstan Medical, Tau-Pnu Medical and Thubrikar Aortic Valve.
Excision Medical was founded in 2020.
Excision Medical's headquarters is located in Malvern, PA, US.
Excision Medical's most recent funding round was for $2.5M (USD) in September 2022.
As of Sep 15, 2022, Excision Medical has disclosed funding of $2.5M (USD). Undisclosed round amounts are excluded.
Excision Medical has 5 employees as of Feb 5, 2024.
Thubrikar Aortic Valve
tavi.us
